Table 4.
Correlation of (log)SFRP4 concentration with baseline characteristics
| Characteristic | No. | Log(SRFP4) | Spearman’s Rho | p-Value |
|---|---|---|---|---|
| Mean ± SEM | ||||
| Previous myocardial infarction | 0.13 | 0.007 | ||
| No | 282 | 1.04 ± 0.1 | ||
| Yes | 222 | 1.08 ± 0.1 | ||
| Previous PCI | 0.17 | 0.001 | ||
| No | 167 | 1.03 ± 0.1 | ||
| Yes | 337 | 1.07 ± 0.1 | ||
| Previous cardiac bypass operation | 0.13 | 0.005 | ||
| No | 441 | 1.05 ± 0.1 | ||
| Yes | 63 | 1.10 ± 0.1 | ||
| Previous stroke | 0.11 | 0.026 | ||
| No | 451 | 1.05 ± 0.1 | ||
| Yes | 53 | 1.10 ± 0.2 | ||
| T2DM | 0.11 | 0.011 | ||
| No | 266 | 1.04 ± 0.1 | ||
| Yes | 238 | 1.07 ± 0.1 | ||
| Insulin therapy | 0.17 | 0.001 | ||
| No | 429 | 1.05 ± 0.1 | ||
| Yes | 75 | 1.10 ± 0.2 | ||
| Metabolic syndrome | 0.16 | <0.0001 | ||
| No | 177 | 1.02 ± 0.1 | ||
| Yes | 327 | 1.08 ± 0.1 | ||
Mean (log)SFRP4 concentrations were compared between strata of categorical variables by Spearman’s rank correlation test; no association between SFRP4 and parameters other than the listed.